🔗 Share this article TikTok Content Creators Fueling Parallel Market for Unlicensed Slimming Medication An underground market for unlicensed slimming drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, based on new investigations. Experimental Drug Acquiring Popularity Online The experimental drug, which remains in research studies, is being promoted by social media influencers for its alleged fat-burning properties. Followers are urged to message these accounts directly for supplier links, while also receiving promotional offers. Active Commerce on Social Networks Separately, a flourishing trade exists on Telegram, where groups with thousands of members share “before and after” photos, injection guides and claims of rapid British shipping. Sellers market the substance there before directing customers to WhatsApp for transactions. Learning About Retatrutide This medication is an investigational injectable created by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials suggest it could help individuals reduce up to 25% of their body weight. Nicknamed the “triple G”, the substance is being promoted digitally as the next Ozempic. Healthcare Professionals Voice Concerns However, doctors and pharmacists have warned that the distribution of what is still an unlicensed medication in the United Kingdom is a cause for concern and could result in individuals injecting substances of uncertain source. Several professionals stated the demand for the experimental drug could be linked to the increasing cost of approved slimming treatments such as Mounjaro. Regulatory Status and Enforcement Marketing the unapproved drug on social media or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that must not be promoted or distributed for personal consumption under the Human Medicines Regulations 2012. Several content creators attempt to sidestep the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but promotion and distribution can still violate pharmaceutical, marketing, and consumer laws, potentially leading to penalties, prosecution or prison. Service Response and Content Elimination Based on TikTok, the platform has taken down problematic content and banned associated keywords and search suggestions. The organization said it was committed to keeping the service safe and allocating resources in enhancing enforcement strategies. Online Marketplace Activities Research also found groups with up to 9,000 members marketing retatrutide using the platform's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” instantly brings up channels with numerous of members, populated with photos of slimming results, positive testimonials and detailed instructions for preparing or administering at home. After minutes of entering one group, a seller posted contact information, where most purchases occur. The vendor provided an guidebook and guaranteed delivery within 48 hours. When questioned whether the substance was genuine, one seller responded: “You can’t be sure.” Another provided a image of a supposed testing documentation. None inquired about weight, medical conditions or previous experience. Product Details and Pricing Inside these communities, posts show dark colored packages with postal service labels, stating to contain new batches. One communication read: “It took eight of us to load them this morning.” Buyers can select between dry substance containers, mixed at residence with purified liquid, or ready-to-use injectors typically sold at 160 pounds for 20mg. When questioned how long a injector should be used, sellers give contradictory answers ranging from a several days to “depends on your body”. Service Oversight and Security Measures A spokesperson for Telegram stated it regularly moderated dangerous content on its service including content that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”. Medical Professional Cautions “Individuals are injecting substances they can’t verify. Even if the research behind this drug is valid, these digital products may not contain what they claim,” said a pharmacy expert, the head of pharmacy at a pharmacy service. Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to current price rises for approved weight-loss medications such as Mounjaro. “With costs increasing, individuals are using social media. But fake injections are extremely risky. You cannot know what’s contained or whether the environment they were made in was clean,” she said. Her staff has previously encountered individuals injured by self-injection from unverified sources. “We understand the disappointment, but purchasing from messaging apps or WhatsApp is gambling with your well-being,” said Wyllie. “These materials could be impure or incorrectly dosed.” Producer Statement A representative from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this time no one can market [it] for human use,” they said, noting that any item “falsely representing itself as a company investigational substance not yet approved … may expose patients to potentially significant health risks”.